Transcriptional and translational markers of syncytialization and biochemical differentiation are significantly decreased by rotenone. by O’Llenecia S. Walker (8486163)

“…Bars with different letters differ significantly at P < 0.01 (A), P < 0.05 (B, D), P < 0.0001 (C, E), P < 0.001 (F).…”

Immunohistochemical analysis of p-Akt expression in various experimental groups showing negative expression in control group, marked increased expression along the extended fibrous bands (upper insert) in TAA group, significant dose-related decreased expression following the decreased fibroplasia in RBO treated groups, and limited expression in SIL treated group. by Rehab F. Abdel-Rahman (11886404)

Spleen PAX5 significantly decreased in APRIL/BLyS blockade treated mice. by Natalie M. Bath (6316517)

Food intake in groups A, B and C. by Sohail Afzal (10850709)

Subjects:

Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity. by Fei San Lee (17282886)

“…Axon length ratio data shows the median and interquartile range of DRG replicates tested per group. Cytotoxicity data shows a scatter plot of each DRG replicate pooled from male and female rats with bar graph centered to the mean and error bars representing standard deviation. …”

Laser irradiation in the PBMT group. by Katayoon Montazeri (18389243)

Subjects:

The number of gauging cross-sections where a statistically significant decreasing trend was identified. by Krzysztof Kochanek (835532)

“…<p>The number of gauging cross-sections where a statistically significant decreasing trend was identified.…”

Decrease of the mean number of natural teeth and POPs with age. by Sul-Hee Kim (11873853)

“…<p>The number of (A) natural teeth and (B) POPs significantly decreased with age in both males and females (<i>P</i> < 0.001). …”

Significant decrease of the viability of A375 melanoma cells after CD treatment. by Lena Berning (7430117)

Doublecortin (DCX) expression in 3 brain regions (coronal sections) in the control (Cont), Tinnitus (TIN) and PBMT (PBMT) groups. by Katayoon Montazeri (18389243)

Subjects:

Bar graphs of DCX expression evaluated in three brain regions in the control (Cont), Tinnitus (TIN) and PBMT (PBMT) groups. by Katayoon Montazeri (18389243)

Subjects:

Mean±SD of BTT and threshold in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Diarrheal disease severity by treatment group for the modified intent-to-treat population. by Rahsan Erdem (11726357)

Subjects:

Mean total cholesterol levels over time in the roxadustat group (A) and ESAs group (B) according to the statins subgroup. by Jie Liu (15128)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Between groups comparison of BTT and threshold in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects:

Immunohistochemical analysis of PDGF-BB expression in various experimental groups; showing negative expression in control group, significant increased along the fibrous septa and along the sinusoidal areas (upper insert) in TAA administrated group, significant dose related decreased expression in RBO which showing scattered expression in the sinusoidal areas, and mild expression along the incomplete septa as well as in sinusoidal areas in silymarin treated group. by Rehab F. Abdel-Rahman (11886404)

Between-groups comparison of GIN and PPI values in control, tinnitus and PBMT groups. by Katayoon Montazeri (18389243)

Subjects: